Characterization of the brain-specific non-AT1, non-AT2 angiotensin binding site in the mouse

European Journal of Pharmacology

Volumn 590, Issue 1-3, 2008, Pages 87-92

  Karamyan, Vardan T ^a   Gembardt, Florian ^b,c   Rabey, Felicia M ^a   Walther, Thomas ^b,d   Speth, Robert C ^a,e  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF HULL   (United Kingdom)

^e UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

125I angiotensin II; Angiotensin (AT) receptor knockout; Mas protein; Neprilysin; Parachloromercuribenzoic acid; Plasma membrane; Redox state; Subcellular distribution; Transgenic

Indexed keywords

4 AMINOPHENYLALANINE; 4 CHLOROMERCURIBENZOIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN 1B RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN DERIVATIVE; ANGIOTENSIN I; ANGIOTENSIN II [1 SARCOSINE 8 ISOLEUCINE]; ANGIOTENSIN II [3-8]; ANGIOTENSIN II [6 PARA AMINOPHENYLALANINE]; ANGIOTENSIN II DERIVATIVE; ANGIOTENSIN III; ANGIOTENSIN[1-7]; BRADYKININ; GONADORELIN; IODINE 125; MEMBRANE METALLOENDOPEPTIDASE; NEUROTENSIN; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE; SUBSTANCE P; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN; BRAIN CORTEX; BRAIN MEMBRANE; CELL MEMBRANE; CONTROLLED STUDY; FEMALE; FRACTIONATION; HYPOTHALAMUS; MALE; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE MAS; PRIORITY JOURNAL; RECEPTOR BINDING;

ANGIOTENSIN II; ANIMALS; BINDING SITES; BRAIN; CEREBRAL CORTEX; FEMALE; HYPOTHALAMUS; MALE; MICE; MICE, INBRED C57BL; P-CHLOROMERCURIBENZOIC ACID; RECEPTORS, ANGIOTENSIN;

EID: 48049084746     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.05.035     Document Type: Article

References (55)

1. Albiston A.L., McDowall S.G., Matsacos D., Sim P., Clune E., Mustafa T., Lee J., Mendelsohn F.A., Simpson R.J., Connolly L.M., and Chai S.Y. Evidence that the angiotensin IV (AT4) receptor is the enzyme insulin regulated aminopeptidase. J. Biol. Chem. 276 (2001) 48623-48626
2. Beer S.M., Taylor E.R., Brown S.E., Dahm C.C., Costa N.J., Runswick M.J., and Murphy M.P. Glutaredoxin 2 catalyzes the reversible oxidation and glutathionylation of mitochondrial membrane thiol proteins: implications for mitochondrial redox regulation and antioxidant DEFENSE. J. Biol. Chem. 279 (2004) 47939-47951
3. Biswas S., Chida A.S., and Rahman I. Redox modifications of protein-thiols: emerging roles in cell signaling. Biochem. Pharmacol. 71 (2006) 551-564
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
5. Chu T.G., and Orlowski M. Soluble metalloendopeptidase from rat brain: action on enkephalin-containing peptides and other bioactive peptides. Endocrinology 116 (1985) 1418-1425
6. Civelli O. Functional genomics: the search for novel neurotransmitters and neuropeptides. FEBS Lett. 430 (1998) 55-58
7. Civelli O., Nothacker H.P., and Reinscheid R. Reverse physiology: discovery of the novel neuropeptide, orphanin FQ/nociceptin. Crit. Rev. Neurobiol. 12 (1998) 163-176
8. Dahms P., and Mentlein R. Purification of the main somatostatin-degrading proteases from rat and pig brains, their action on other neuropeptides, and their identification as endopeptidases 24.15 and 24.16. Eur. J. Biochem. 208 (1992) 145-154
9. Dando P.M., Brown M.A., and Barrett A.J. Human thimet oligopeptidase. Biochem. J. 294 Pt 2 (1993) 451-457
10. Ferrario C.M., and Chappell M.C. Novel angiotensin peptides. Cell Mol. Life Sci. 61 (2004) 2720-2727
11. Gehlert D.R., Speth R.C., and Wamsley J.K. Distribution of [125I]angiotensin II binding sites in the rat brain: a quantitative autoradiographic study. Neuroscience 18 (1986) 837-856
12. Gembardt, F., Heringer-Walther, S., van Esch, J.H.M., Sterner-Kock, A., van Veghel, R., Le, T.H., Garrelds, I.M., Coffman, T.M., Danser, A.H.J., Schultheiss, H.-P., Walther, T., in press. Cardiovascular phenotype of mice lacking all three subtypes of angiotensin II receptors. FASEB J. 22. doi:10.1096/fj.08-108316.
13. Ghezzi P., Bonetto V., and Fratelli M. Thiol-disulfide balance: from the concept of oxidative stress to that of redox regulation. Antioxid. Redox. Signal 7 (2005) 964-972
14. Gray E.G., and Whittaker V.P. The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation. J. Anat. 96 (1962) 79-88
15. Hagiwara H., Sugiura N., Wakita K., and Hirose S. Purification and characterization of angiotensin-binding protein from porcine liver cytosolic fraction. Eur. J. Biochem. 185 (1989) 405-410
16. Ito M., Oliverio M.I., Mannon P.J., Best C.F., Maeda N., Smithies O., and Coffman T.M. Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 3521-3525
17. Karamyan V., and Speth R. Enzymatic pathways of the brain renin-angiotensin system: unsolved problems and continuing challenges. Regul. Pept. 143 (2007) 15-27
18. Karamyan V.T., and Speth R.C. Identification of a novel non-AT1, non-AT2 angiotensin binding site in the rat brain. Brain Res. 1143 (2007) 83-91
19. Kato A., Sugiura N., Hagiwara H., and Hirose S. Cloning, amino acid sequence and tissue distribution of porcine thimet oligopeptidase. A comparison with soluble angiotensin-binding protein. Eur. J. Biochem. 221 (1994) 159-165
20. Kato A., Sugiura N., Saruta Y., Hosoiri T., Yasue H., and Hirose S. Targeting of endopeptidase 24.16 to different subcellular compartments by alternative promoter usage. J. Biol. Chem. 272 24 (1997) 15313-15322 Ref Type: Journal (Full)
21. Kiron M.A., and Soffer R.L. Purification and properties of a soluble angiotensin II-binding protein from rabbit liver. J. Biol. Chem. 264 (1989) 4138-4142
22. Kokje R.J., Wilson W.L., Brown T.E., Karamyan V.T., Wright J.W., and Speth R.C. Central pressor actions of aminopeptidase-resistant angiotensin II analogs: challenging the angiotensin III hypothesis. Hypertension 49 (2007) 1328-1335
23. Leichert L.I., and Jakob U. Global methods to monitor the thiol-disulfide state of proteins in vivo. Antioxid. Redox. Signal 8 (2006) 763-772
24. Maher P. Redox control of neural function: background, mechanisms, and significance. Antioxid. Redox. Signal 8 (2006) 1941-1970
25. McKie N., Dando P.M., Rawlings N.D., and Barrett A.J. Thimet oligopeptidase: similarity to 'soluble angiotensin II-binding protein' and some corrections to the published amino acid sequence of the rat testis enzyme. Biochem. J. 295 (1993) 57-60
26. Mendelsohn F.A., Quirion R., Saavedra J.M., Aguilera G., and Catt K.J. Autoradiographic localization of angiotensin II receptors in rat brain. Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 1575-1579
27. Nagata S., Kato J., Sasaki K., Minamino N., Eto T., and Kitamura K. Isolation and identification of proangiotensin-12, a possible component of the renin-angiotensin system. Biochem. Biophys. Res. Commun. 350 (2006) 1026-1031
28. Nguyen G. The (pro)renin receptor: a new kid in town. Semin. Nephrol. 27 (2007) 519-523
29. Norman M.U., Lew R.A., Smith A.I., and Hickey M.J. Metalloendopeptidases EC 3.4.24.15/16 regulate bradykinin activity in the cerebral microvasculature. Am. J. Physiol. Heart Circ. Physiol. 284 (2003) H1942-H1948
30. Oliverio M.I., Kim H.S., Ito M., Le T., Audoly L., Best C.F., Hiller S., Kluckman K., Maeda N., Smithies O., and Coffman T.M. Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II. Proc. Natl. Acad. Sci. U.S.A 95 (1998) 15496-15501
31. Phillips M.I., and Sumners C. Angiotensin II in central nervous system physiology. Regul. Pept. 78 (1998) 1-11
32. Reaux A., Fournie-Zaluski M.C., and Llorens-Cortes C. Angiotensin III: a central regulator of vasopressin release and blood pressure. Trends Endocrinol. Metab. 12 (2001) 157-162
33. Rioli V., Kato A., Portaro F.C., Cury G.K., te K.K., Vincent B., Checler F., Camargo A.C., Glucksman M.J., Roberts J.L., Hirose S., and Ferro E.S. Neuropeptide specificity and inhibition of recombinant isoforms of the endopeptidase 3.4.24.16 family: comparison with the related recombinant endopeptidase 3.4.24.15. Biochem. Biophys. Res. Commun. 250 (1998) 5-11
34. Saavedra J.M. Brain and pituitary angiotensin. Endocr. Rev. 13 (1992) 329-380
35. Saavedra J.M. Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities. Cell Mol. Neurobiol. 25 (2005) 485-512
36. Santos R.A., Simoes e Silva A., Maric C., Silva D.M., Machado R.P., de I B., Heringer-Walther S., Pinheiro S.V., Lopes M.T., Bader M., Mendes E.P., Lemos V.S., Campagnole-Santos M.J., Schultheiss H.P., Speth R., and Walther T. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc. Natl. Acad. Sci. U.S.A 100 (2003) 8258-8263
37. Saria A., Hauser K.F., Traurig H.H., Turbek C.S., Hersh L., and Gerard C. Opioid-related changes in nociceptive threshold and in tissue levels of enkephalins after target disruption of the gene for neutral endopeptidase (EC 3.4.24.11) in mice. Neurosci. Lett. 234 (1997) 27-30
38. Satoh T., and Lipton S.A. Redox regulation of neuronal survival mediated by electrophilic compounds. Trends Neurosci. 30 (2007) 37-45
39. Severs W.B., and Daniels-Severs A.E. Effects of angiotensin on the central nervous system. Pharmacol. Rev. 25 (1973) 415-449
40. Shrimpton C.N., Abbenante G., Lew R.A., and Smith I. Development and characterization of novel potent and stable inhibitors of endopeptidase EC 3.4.24.15. Biochem. J. 345 Pt 2 (2000) 351-356
41. Shrimpton C.N., Wolfson A.J., Smith A.I., and Lew R.A. Regulators of the neuropeptide-degrading enzyme, EC 3.4.24.15 (thimet oligopeptidase), in cerebrospinal fluid. J. Neurosci. Res. 74 (2003) 474-478
42. Speth R.C. Sarcosine1,glycine8 angiotensin II is an AT1 angiotensin II receptor subtype selective antagonist. Regul. Pept. 115 (2003) 203-209
43. Speth R.C., Brown T.E., Barnes R.D., and Wright J.W. Brain angiotensinergic activity: the state of our current knowledge. Proc. West Pharmacol. Soc. 46 (2003) 11-15
44. Speth R.C., and Harding J.W. Radiolabeling of Angiotensin Peptides. In: Wang D.H. (Ed). Angiotensin Protocols vol. 51 (2001), Humana Press, Totowa, NJ 275-295
45. Speth R.C., and Karamyan V.T. The significance of brain aminopeptidases in the regulation of the actions of angiotensin peptides in the brain. Heart Fail. Rev. 13 (2008) 299-309
46. 6 angiotensin II. Biochem. Biophys. Res. Commun. 169 (1990) 997-1006
47. Stadel J.M., Wilson S., and Bergsma D.J. Orphan G protein-coupled receptors: a neglected opportunity for pioneer drug discovery. Trends Pharmacol. Sci. 18 (1997) 430-437
48. Turner A.J., Tipnis S.R., Guy J.L., Rice G., and Hooper N.M. ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors. Can. J. Physiol. Pharmacol. 80 (2002) 346-353
49. Unger T., Badoer E., Ganten D., Lang R.E., and Rettig R. Brain angiotensin: pathways and pharmacology. Circulation 77 (1988) I40-I54
50. Velu C.S., Niture S.K., Doneanu C.E., Pattabiraman N., and Srivenugopal K.S. Human p53 is inhibited by glutathionylation of cysteines present in the proximal DNA-binding domain during oxidative stress. Biochemistry 46 (2007) 7765-7780
51. von Bohlen Und Halbach O. The renin-angiotensin system in the mammalian central nervous system. Curr. Protein Pept. Sci. 6 (2005) 355-371
52. von Bohlen und H.O., and Albrecht D. The CNS renin-angiotensin system. Cell Tissue Res. 326 (2006) 599-616
53. Walther T., Balschun D., Voigt J.P., Fink H., Zuschratter W., Birchmeier C., Ganten D., and Bader M. Sustained long term potentiation and anxiety in mice lacking the Mas protooncogene. J. Biol. Chem. 273 (1998) 11867-11873
54. Whitebread S., Mele M., Kamber B., and de Gasparo M. Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem. Biophys. Res. Commun. 163 (1989) 284-291
55. Zimmerman M.C., and Davisson R.L. Redox signaling in central neural regulation of cardiovascular function. Prog. Biophys. Mol. Biol. 84 (2004) 125-149